Purine and pyrimidine metabolism disorders - Insights
Check out how Mayo Clinic Laboratories’ genetic testing can help to diagnose and monitor patients affected by purine and pyrimidine metabolism disorders.
In vitro diagnostics solutions - Insights
BioPharma Diagnostics supports medical device, biopharma, and diagnostic companies with in vitro diagnostic services, including analytical validation of new assays and devices in compliance with CAP/CLIA requirements.
Pharmaceutical solutions - Insights
We believe the pharmaceutical industry and clinical research partners can improve global health through innovative drug discovery and development — and that you deserve the best reference lab partner at your side. Mayo Clinic BioPharma...
Mayo Clinic Laboratories’ genetic counselors are experts on heritable illness who provide a wealth of knowledge to guide appropriate testing utilization and interpret results.
Learn more about how our flexible lab space and expert staff can help you meet your diagnostic needs.
Mayo Clinic Laboratories’ targeted testing for opioids uses high-resolution mass spectrometry to detect 33 different opioids.
Mayo Clinic Laboratories’ targeted benzodiazepine testing uses high-resolution mass spectrometry to identify 27 different benzodiazepines and metabolites in the urine.
Emergency toxicology - Insights
Mayo Clinic Laboratories’ emergency toxicology testing can help providers manage overdose by clarifying whether symptoms are due to the presence of drugs.
New tests launched in September - Insights
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Myelodysplastic syndrome - Insights
Browse our wide variety of testing options for the prognosis and risk stratification associated with myelodysplastic syndrome.